Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Paravertebral Catheters for Pancreatic Surgery

30 augusti 2017 uppdaterad av: University of Minnesota

Ultrasound Guided Bilateral Paravertebral Catheters Versus Thoracic Epidural Analgesia for Post- Operative Pain Control in Open Pancreatic Surgery: A Prospective Outcomes Study

Design: Level I randomized prospective outcomes study comparing two groups of patients. One group will receive bupivacaine and dilaudid thoracic epidural analgesia (PCA) post-operatively. The other will receive bilateral ultrasound guided paravertebral blocks with indwelling paravertebral catheters with an infusion of 0.2% ropivicaine post-operatively and a PCA.

Sample Size: 50 patients Study Duration: Approximately 12 months Population:. Patients presenting to the University of Minnesota Medical Center for elective open pancreatic surgery.

Primary Objective: To determine if bilateral paravertebral catheters in patients with open pancreatic procedures result in decreased pain compared to patients treated with thoracic epidural for post-operative pain.

Secondary Objectives:

  1. To determine whether the use of bilateral paravertebral catheters impacts the length of ICU and hospital stay for patients, compared to a thoracic epidurals in patients undergoing elective open pancreatic surgery.
  2. To determine whether the use of ultrasound guided bilateral paravertebral catheters leads to lower risk of complications, compared to use of a thoracic epidural in patients undergoing open pancreatic surgery.

Studieöversikt

Status

Avslutad

Betingelser

Detaljerad beskrivning

Design: Level I randomized prospective outcomes study comparing two groups of patients. One group will receive buipvacanine and dilaudid thoracic epidural analgesia (PCA) post-operatively. The other will receive bilateral ultrasound guided paravertebral blocks with indwelling paravertebral catheters with an infusion of 0.2% ropivicaine post-operatively and a PCA.

Sample Size: 50 patients Study Duration: Approximately 12 months Population:. Patients presenting to the University of Minnesota Medical Center for elective open pancreatic surgery.

Primary Objective: To determine if bilateral paravertebral catheters in patients with open pancreatic procedures result in decreased total maximal pain scores compared to patients treated with thoracic epidural for post-operative pain.

Secondary Objectives:

  1. To determine whether the use of bilateral paravertebral catheters impacts the length of ICU and hospital stay for patients, compared to a thoracic epidurals in patients undergoing elective open pancreatic surgery.
  2. To determine whether the use of ultrasound guided bilateral paravertebral catheters leads to lower risk of complications, compared to use of a thoracic epidural in patients undergoing open pancreatic surgery.

2. Synopsis and Medical Application:

Specific Aims:

Primary Hypothesis: Paravertebral catheters will result in improved pain control relative to thoracic epidural for post-operative pain from open pancreatic surgery.

Secondary Hypothesis: Paravertebral catheters will result in fewer hospital days and improved subjective respiratory function compared to patients in the thoracic epidural group.

Studietyp

Interventionell

Inskrivning (Faktisk)

50

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Minnesota
      • Minneapolis, Minnesota, Förenta staterna, 55455
        • University of Minnesota

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 85 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • • All patients undergoing open pancreatic surgery.

Exclusion Criteria:

  • • Previous difficult airway or multiple previous intubations

    • History of myasthenic syndrome
    • Systemic infection
    • Pre-existing sensory deficit
    • PT >14 or PTT >40 sec
    • Platelet count less than 50,000
    • Creatinine > 1.5
    • Allergy to local anesthetics
    • Patients who remain intubated for one week after surgery or who are unable to provide information as to their feelings of pain post-operatively for the first week post-operatively
    • Use of a spinal or epidural anesthetic for surgery
    • Daily use of opioid for more than a week or chronic pain syndrome
    • Lack of patient cooperation
    • Contraindication to regional anesthesia

      • Infection at injection site
      • Inability to guarantee sterile equipment or sterile conditions for the block
      • Patient refusal
      • Risk of local anesthetic toxicity
      • Coagulopathy or bleeding disorder
      • Severe respiratory disease (where the patient depends on intercostal muscle function for ventilation);
      • Ipsilateral diaphragmatic paresis;

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Aktiv komparator: Standard of Care
Epidural placed for postoperative pain control
A mid thoracic epidural is placed preoperatively and a local anesthetic and opioid infusion is run postoperatively
Experimentell: Experimental Intervention
Bilateral paravertebral catheters placed for postoperative pain control
Bilateral paravertebral catheters are placed and a local anesthetic infusion via an elastomeric pump is run postoperatively

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
total Maximal Pain scored via NRS 0-10 scale
Tidsram: on postoperative day 1 through postoperative day 5
maximal pain scored via NRS 0-10 scale assessed by independent assessor
on postoperative day 1 through postoperative day 5

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Maximal Pain scored via NRS 0-10 scale
Tidsram: on postoperative day 1
maximal pain scored via NRS 0-10 scale assessed by independent assessor
on postoperative day 1
Maximal Pain scored via NRS 0-10 scale
Tidsram: on postoperative day 2
maximal pain scored via NRS 0-10 scale assessed by independent assessor
on postoperative day 2
Maximal Pain scored via NRS 0-10 scale
Tidsram: on postoperative day 3
maximal pain scored via NRS 0-10 scale assessed by independent assessor
on postoperative day 3
Maximal Pain scored via NRS 0-10 scale
Tidsram: on postoperative day 4
maximal pain scored via NRS 0-10 scale assessed by independent assessor
on postoperative day 4
Maximal Pain scored via NRS 0-10 scale
Tidsram: on postoperative day 5
maximal pain scored via NRS 0-10 scale assessed by independent assessor
on postoperative day 5
Nausea/vomiting
Tidsram: the first five days postoperatively
the presence of nausea and or vomiting endorsed by the patient as assessed by an independent assessor
the first five days postoperatively
Length of stay
Tidsram: when the patient meets discharge criteria or is discharged home, expected length of stay 10 days
up through the time the patient is discharged , expected length of stay 10 days.
when the patient meets discharge criteria or is discharged home, expected length of stay 10 days

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 augusti 2012

Primärt slutförande (Faktisk)

1 december 2015

Avslutad studie (Faktisk)

1 juni 2016

Studieregistreringsdatum

Först inskickad

3 februari 2015

Först inskickad som uppfyllde QC-kriterierna

13 februari 2015

Första postat (Uppskatta)

16 februari 2015

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

31 augusti 2017

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

30 augusti 2017

Senast verifierad

1 augusti 2017

Mer information

Termer relaterade till denna studie

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • 1203M11482

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Akut smärta

Kliniska prövningar på Epidural

3
Prenumerera